<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Adenosine</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00640</strong>&#160; (APRD00132)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved, investigational</td></tr><tr><th>Description</th><td><p>A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of <span class="caps">DNA</span> and <span class="caps">RNA</span>. Adenosine itself is a neurotransmitter. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00640/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00640/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00640.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00640.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00640.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00640.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00640.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00640">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Adenin riboside</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>IS</td></tr><tr><td>Adenosin</td><td>German</td><td>INN</td></tr><tr><td>Adenosina</td><td>Spanish</td><td>INN</td></tr><tr><td>Ad&#233;nosine</td><td>French</td><td>INN</td></tr><tr><td>Adenosinum</td><td>Latin</td><td>INN</td></tr><tr><td>Ado</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>IS</td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Adenocard</td><td>Astellas</td></tr><tr><td>Adenocor</td><td>Sanofi-Aventis</td></tr><tr><td>Adenoject</td><td>Sun</td></tr><tr><td>Ad&#233;noscan</td><td>Sanofi-Aventis</td></tr><tr><td>Adenoscan</td><td>Astellas</td></tr><tr><td>Adenoz</td><td>Celon</td></tr><tr><td>Adenozer</td><td>Purzer</td></tr><tr><td>Adesin</td><td>Dae Han New Pharm</td></tr><tr><td>Adrekar</td><td>Sanofi-Aventis</td></tr><tr><td>At&#233;pad&#232;ne</td><td>Mayoly-Spindler</td></tr><tr><td>Cardimax</td><td>AC Farma</td></tr><tr><td>Cardiovert</td><td>Sanofi-Aventis</td></tr><tr><td>Krenosin</td><td>Sanofi-Aventis</td></tr><tr><td>Osiden</td><td>Square</td></tr><tr><td>Pisdeno</td><td>Pisa</td></tr><tr><td>Tricor</td><td>Sanofi-Aventis</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/anti-arrhythmia-agents">Anti-Arrhythmia Agents</a></li>
<li><a href="/mesh/analgesics">Analgesics</a></li>
<li><a href="/mesh/vasodilator-agents">Vasodilator Agents</a></li>
<li><a href="/mesh/cardiovascular-agents">Cardiovascular Agents</a></li></ul></td></tr><tr><th>CAS number</th><td>58-61-7</td></tr><tr><th>Weight</th><td>Average: 267.2413<br>Monoisotopic: 267.096753929</td></tr><tr><th>Chemical Formula</th><td>C<sub>10</sub>H<sub>13</sub>N<sub>5</sub>O<sub>4</sub></td></tr><tr><th>InChI Key</th><td>OIRDTQYFTABQOQ-KQYNXXCUSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol</div></td></tr><tr><th>SMILES</th><td><div class="wrap">NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1</div></td></tr><tr><th>Mass Spec</th><td><a href="/system/mass_specs/DB00640.gif?1265922774">show</a>(9.12 KB)</td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Organooxygen Compounds</td></tr><tr><th>Class</th><td>Carbohydrates and Carbohydrate Conjugates</td></tr><tr><th>Subclass</th><td>Glycosyl Compounds</td></tr><tr><th>Direct parent</th><td>Purine Nucleosides and Analogues</td></tr><tr><th>Alternative parents</th><td>Pentoses; Purines and Purine Derivatives; Aminopyrimidines and Derivatives; N-substituted Imidazoles; Primary Aromatic Amines; Tetrahydrofurans; Oxolanes; Secondary Alcohols; 1,2-Diols; Ethers; Primary Alcohols; Polyamines</td></tr><tr><th>Substituents</th><td>pentose monosaccharide; imidazopyrimidine; purine; aminopyrimidine; primary aromatic amine; pyrimidine; monosaccharide; n-substituted imidazole; tetrahydrofuran; imidazole; azole; oxolane; secondary alcohol; 1,2-diol; polyamine; primary alcohol; ether; organonitrogen compound; primary amine; alcohol; amine</td></tr><tr><th>Classification description</th><td>This compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>Used as an initial treatment for the termination of paroxysmal supraventricular tachycardia (PVST), including that associated with accessory bypass tracts, and is a drug of choice for terminating stable, narrow-complex supraventricular tachycardias (SVT). Also used as an adjunct to thallous chloride TI 201 myocardial perfusion scintigraphy (thallium stress test) in patients who are unable to exercise adequately, as well as an adjunct to vagal maneuvers and clinical assessment to establish a specific diagnosis of undefined, stable, narrow-complex SVT.</td></tr><tr><th>Pharmacodynamics</th><td>Adenosine is an endogenous nucleoside occurring in all cells of the body and is not chemically related to other antiarrhythmic drugs. Adenosine may exert its pharmacologic effects by activation of purine (cell surface A<sub>1</sub> and A<sub>2</sub> adenosine) receptors, as well as relax vascular smooth muscles through the reduction in calcium uptake by inhibition of slow inward calcium current and activation of adenylate cyclase in smooth muscle cells. Adenosine may reduce vascular tone by modulation of sympathetic neurotransmission. The drug also has negative chronotropic, dromotropic, and inotropic effects on the heart by slowing conduction time throught he AV node and interrupting AV nodal reentry pathways. Adenosine is a potent vasodilator in most vascular beds, but vasoconstriction is produced in renal afferent arterioles and hepatic veins. The drug produces a net mild to moderate reduction in systolic, diastolic, and mean arterial blood pressure and a reflex increase in heart rate. Adenosine is antagonized competitively by methylxanthines such as caffeine and theophylline, and potentiated by blockers of nucleoside transport such as dipyridamole. Adenosine is not blocked by atropine.</td></tr><tr><th>Mechanism of action</th><td>Adenosine slows conduction time through the AV node and can interrupt the reentry pathways through the AV node, resulting in the restoration of normal sinus rhythm in patients with paroxysmal supraventricular tachycardia (PSVT), including PSVT associated with Wolff-Parkinson-White Syndrome. This effect may be mediated through the drug's activation of cell-surface A<sub>1</sub> and A<sub>2</sub> adenosine receptors. Adenosine also inhibits the slow inward calcium current and activation of adenylate cyclase in smooth muscle cells, thereby causing relaxation of vascular smooth muscle. By increasing blood flow in normal coronary arteries with little or no increase in stenotic arteries (with little to no increase in stenotic arteries), adenosine produces a relative difference in thallous (thallium) chloride TI 201 uptake in myocardium supplied by normal verus stenotic coronary arteries.</td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Intracellular adenosine is rapidly metabolized either via phosphorylation to adenosine monophosphate by adenosine kinase, or via deamination to inosine by adenosine deaminase in the cytosol.</p><table class="table-standard table-condensed" id="experimental-properties"><thead><tr><th>Substrate</th><th>Enzymes</th><th colspan="2">Product</th></tr></thead><tbody><tr><td>Adenosine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00485">Adenosine monophosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/499">Details</a></td></tr><tr><td>Adenosine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00496">Inosine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/510">Details</a></td></tr></tbody></table></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td>Less than 10 secs</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th></tr></thead><tbody><tr><td>Intracellular Signalling Through Adenosine Receptor A2a and Adenosine</td><td>Signaling</td></tr><tr><td>Intracellular Signalling Through Adenosine Receptor A2b and Adenosine</td><td>Signaling</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00321?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00321</a></td></tr><tr><td>Selenoamino Acid Metabolism</td><td>Metabolic</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00029?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00029</a></td></tr><tr><td>Thioguanine Action Pathway</td><td>Drug action</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00430?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00430</a></td></tr><tr><td>Azathioprine Action Pathway</td><td>Drug action</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00427?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00427</a></td></tr><tr><td>Mercaptopurine Action Pathway</td><td>Drug action</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00428?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00428</a></td></tr><tr><td>Adenine phosphoribosyltransferase deficiency (APRT)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00535?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00535</a></td></tr><tr><td>Adenosine Deaminase Deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00144?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00144</a></td></tr><tr><td>S-Adenosylhomocysteine (SAH) Hydrolase Deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00214?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00214</a></td></tr><tr><td>Methionine Adenosyltransferase Deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00221?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00221</a></td></tr><tr><td>Adenylosuccinate Lyase Deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00167?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00167</a></td></tr><tr><td>AICA-Ribosiduria</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00168?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00168</a></td></tr><tr><td>Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00570?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00570</a></td></tr><tr><td>Cystathionine Beta-Synthase Deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00177?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00177</a></td></tr><tr><td>Betaine Metabolism</td><td>Metabolic</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00123?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00123</a></td></tr><tr><td>Molybdenium Cofactor Deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00203?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00203</a></td></tr><tr><td>Myoadenylate deaminase deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00537?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00537</a></td></tr><tr><td>Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00340?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00340</a></td></tr><tr><td>Glycine N-methyltransferase Deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00222?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00222</a></td></tr><tr><td>Xanthine Dehydrogenase Deficiency (Xanthinuria)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00220?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00220</a></td></tr><tr><td>Purine Nucleoside Phosphorylase Deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00210?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00210</a></td></tr><tr><td>Mitochondrial DNA depletion syndrome</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00536?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00536</a></td></tr><tr><td>Gout or Kelley-Seegmiller Syndrome</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00365?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00365</a></td></tr><tr><td>Hypermethioninemia</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00341?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00341</a></td></tr><tr><td>Xanthinuria type I</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00512?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00512</a></td></tr><tr><td>Xanthinuria type II</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00513?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00513</a></td></tr><tr><td>Lesch-Nyhan Syndrome (LNS)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00364?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00364</a></td></tr><tr><td>Purine Metabolism</td><td>Metabolic</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00050?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00050</a></td></tr><tr><td>Methionine Metabolism</td><td>Metabolic</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00033?highlight%5Bcompounds%5D%5B%5D=DB00640&amp;highlight%5Bproteins%5D%5B%5D=DB00640">SMP00033</a></td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9227</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9383</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.8957</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.7026</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.966</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9533</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9444</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8639</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.8349</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.5866</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9667</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9595</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.977</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9514</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.962</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9701</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9133
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9182
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9738
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          1.9715 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.989
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.9102
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Astellas pharma us inc</li>
<li>Akorn inc</li>
<li>App pharmaceuticals llc</li>
<li>Baxter healthcare corp</li>
<li>Bedford laboratories div ben venue laboratories inc</li>
<li>Gland pharma ltd</li>
<li>Luitpold pharmaceuticals inc</li>
<li>Strides arcolab ltd</li>
<li>Teva parenteral medicines inc</li>
<li>Wockhardt ltd</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.apppharma.com">APP Pharmaceuticals</a></li>
<li><a href="http://orders.a-smeds.com">A-S Medication Solutions LLC</a></li>
<li><a href="http://www.astellas.com">Astellas Pharma Inc.</a></li>
<li><a href="http://www.baxter.com">Baxter International Inc.</a></li>
<li><a href="http://www.bedfordlabs.com">Bedford Labs</a></li>
<li><a href="http://www.benvenue.com">Ben Venue Laboratories Inc.</a></li>
<li><a href="http://www.giv.com">General Injectables and Vaccines Inc.</a></li>
<li><a href="http://www.glandpharma.com">Gland Pharma Ltd.</a></li>
<li><a href="http://www.hospira.com">Hospira Inc.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.sagentpharma.com">Sagent Pharmaceuticals</a></li>
<li><a href="http://www.spectrumpharm.com">Spectrum Pharmaceuticals</a></li>
<li><a href="http://www.stridesarco.com">Strides Arcolab Limited</a></li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li>
<li><a href="http://www.wockhardtin.com">Wockhardt Ltd.</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Liquid</td><td>Intravenous</td><td></td></tr><tr><td>Solution</td><td>Intravenous</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><ul><li><a data-no-turbolink="true" href="/spectra/spectra/c_ms/70">Gas-MS Spectrum</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/nmr_one_d/1053">1H NMR Spectrum</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/nmr_one_d/1131">13C NMR Spectrum</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/81">MS/MS Spectrum Quattro_QQQ 10</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/82">MS/MS Spectrum Quattro_QQQ 25</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/83">MS/MS Spectrum Quattro_QQQ 40</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/2654">MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/2655">MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/2656">MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/2657">MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/2658">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/2659">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/2660">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/2661">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/2662">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/2663">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/2664">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/2665">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/nmr_two_d/943">[1H,1H] 2D NMR Spectrum</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/nmr_two_d/1111">[1H,13C] 2D NMR Spectrum</a></li></ul></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01223">Aminophylline</a></td><td>This xanthine decreases the effect of adenosine</td></tr><tr><td><a href="/drugs/DB00201">Caffeine</a></td><td>Caffeine may diminish the therapeutic effect of adenosine. Specific management recommendations vary slightly depending on specific adenosine product used (i.e., therapeutic vs. diagnostic use of adenosine). Significantly higher adenosine doses, or alternative agents, may be required. Monitor for decreased therapeutic effects of adenosine if the patient is already receiving caffeine. Discontinue caffeine in advance (5 half-lives, or approximately 24 hours, is specifically recommended) of scheduled diagnostic use of adenosine (e.g., for radionuclide imaging studies) whenever possible.</td></tr><tr><td><a href="/drugs/DB00975">Dipyridamole</a></td><td>Dipyridamole may increase the effect/toxicity of adenosine.</td></tr><tr><td><a href="/drugs/DB00651">Dyphylline</a></td><td>This xanthine decreases the effect of adenosine</td></tr><tr><td><a href="/drugs/DB01303">Oxtriphylline</a></td><td>This xanthine decreases the effect of adenosine</td></tr><tr><td><a href="/drugs/DB00277">Theophylline</a></td><td>Theophylline may decrease the effect of adenosine.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Avoid caffeine containing foods and drinks.</li></ul></td></tr></tbody></table>